Marsi-Bionics

Marsi-Bionics is a developer of robotic exoskeletons for children's mobility and gait rehabilitation. The company's products are based on its proprietary ARES technology, which features active joints with variable stiffness that mimic natural muscle function, enabling personalized gait therapy adapted to each patient's needs. The product portfolio includes the Atlas Pediatric Exo, a lower-body exoskeleton designed for clinical rehabilitation of children with neuromuscular diseases and spinal cord injuries; the EXPLORER MB, the first personal-use pediatric exoskeleton designed specifically to assist walking for children aged 2 to 17 with neurodevelopmental disorders in everyday environments such as parks, streets, and schools; and the MB-Active Knee, a robotic knee orthosis that interprets and satisfies patient needs for functional gait, providing superior control and precision during rehabilitation for patients with knee weakness from arthroplasty surgery, stroke, and other conditions. The company also operates Marsi Care, a research and therapy center where patients can participate in clinical research projects and receive advanced physical therapy. Marsi-Bionics' exoskeletons are designed for rehabilitation of over 40 million patients worldwide affected by neurological disorders causing musculoskeletal complications. Founded in 2013 and headquartered in Madrid, Spain, the company has raised $4.9M in Series A funding from investors including Europa, Orilla Asset Management, ALBP, Ion Ion, and Camberi Ventures.

Consumer Robotics > Healthcare > Robotic Assistance > Mobility & Rehabilitation,

Assistive Tech > Assistive Hardware > Mobility > Powered exoskeletons,

Orthopedics > Medical Devices > Therapies > Rehabilitation > Exoskeleton,

Pediatrics > Medical Devices > Therapeutics > Orthopedic Devices > Exoskeletons